Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1987-3-9
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0393-2249
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
38
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
271-8
|
| pubmed:dateRevised |
2008-6-23
|
| pubmed:meshHeading |
pubmed-meshheading:3810389-Bicyclo Compounds,
pubmed-meshheading:3810389-Bicyclo Compounds, Heterocyclic,
pubmed-meshheading:3810389-Bridged Compounds,
pubmed-meshheading:3810389-Cholelithiasis,
pubmed-meshheading:3810389-Colic,
pubmed-meshheading:3810389-Double-Blind Method,
pubmed-meshheading:3810389-Humans,
pubmed-meshheading:3810389-Kidney Diseases
|
| pubmed:articleTitle |
[Clinical evaluation of a new spasmolytic: sintropium bromide (VAL 480) in spastic states of the upper and lower urinary tract].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|